GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » PT Bundamedik Tbk (ISX:BMHS) » Definitions » Cash Flow from Financing

PT Bundamedik Tbk (ISX:BMHS) Cash Flow from Financing : Rp165,981 Mil (TTM As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is PT Bundamedik Tbk Cash Flow from Financing?

Cash from financing is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders.

For the three months ended in Mar. 2024, PT Bundamedik Tbk paid Rp0 Mil more to buy back shares than it received from issuing new shares. It received Rp34,859 Mil from issuing more debt. It paid Rp0 Mil more to buy back preferred shares than it received from issuing preferred shares. It received Rp0 Mil from paying cash dividends to shareholders. It spent Rp0 Mil on other financial activities. In all, PT Bundamedik Tbk earned Rp34,859 Mil on financial activities for the three months ended in Mar. 2024.


PT Bundamedik Tbk Cash Flow from Financing Historical Data

The historical data trend for PT Bundamedik Tbk's Cash Flow from Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PT Bundamedik Tbk Cash Flow from Financing Chart

PT Bundamedik Tbk Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash Flow from Financing
Get a 7-Day Free Trial -15,804.78 383,545.57 158,468.15 106,466.16 153,563.15

PT Bundamedik Tbk Quarterly Data
Dec18 Dec19 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cash Flow from Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15,819.69 -2,369.94 111,881.08 28,232.32 28,237.57

PT Bundamedik Tbk Cash Flow from Financing Calculation

This is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders. In the calculation of free cash flow, cash from financing is not calculated because it is not related to operating activities.

PT Bundamedik Tbk's Cash from Financing for the fiscal year that ended in Dec. 2023 is calculated as:

PT Bundamedik Tbk's Cash from Financing for the quarter that ended in Mar. 2024 is:


Cash Flow from Financing for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was Rp165,981 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PT Bundamedik Tbk  (ISX:BMHS) Cash Flow from Financing Explanation

Cash from financing contains six items:

1. Issuance of Stock:
A company may raise cash from issuing new shares. Issuance of stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.

PT Bundamedik Tbk's issuance of stock for the three months ended in Mar. 2024 was Rp0 Mil.

2. Repurchase of Stock:
A company may raise cash from issuing new shares. It can also use cash to buy back shares. Repurchase of stock represents the cash outflow to reacquire common stock during the period.

PT Bundamedik Tbk's repurchase of stock for the three months ended in Mar. 2024 was Rp0 Mil.

3. Net Issuance of Debt:
Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.

PT Bundamedik Tbk's net issuance of debt for the three months ended in Mar. 2024 was Rp34,859 Mil. PT Bundamedik Tbk received Rp34,859 Mil from issuing more debt.

4. Net Issuance of Preferred Stock:
A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

PT Bundamedik Tbk's net issuance of preferred for the three months ended in Mar. 2024 was Rp0 Mil. PT Bundamedik Tbk paid Rp0 Mil more to buy back preferred shares than it received from issuing preferred shares.

5. Cash Flow for Dividends:
Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

PT Bundamedik Tbk's cash flow for dividends for the three months ended in Mar. 2024 was Rp0 Mil. PT Bundamedik Tbk received Rp0 Mil from paying cash dividends to shareholders.

6. Other Financing:
Money spent or earned by company from other financial activities.

PT Bundamedik Tbk's other financing for the three months ended in Mar. 2024 was Rp-0 Mil. PT Bundamedik Tbk spent Rp0 Mil on other financial activities.


PT Bundamedik Tbk Cash Flow from Financing Related Terms

Thank you for viewing the detailed overview of PT Bundamedik Tbk's Cash Flow from Financing provided by GuruFocus.com. Please click on the following links to see related term pages.


PT Bundamedik Tbk (ISX:BMHS) Business Description

Traded in Other Exchanges
N/A
Address
Jl. Teuku Cik Ditiro No.28, Menteng, Jakarta Pusat, IDN, 10350
PT Bundamedik Tbk is a healthcare service provider. It offers maternal and child health services, outpatient services, inpatient services, emergency services, service excellence centers, IVF services, and Clinical laboratory services.

PT Bundamedik Tbk (ISX:BMHS) Headlines

No Headlines